Skip to main content
. 2021 Feb 28;109(4):816–828. doi: 10.1002/cpt.2185

Table 1.

Self‐controlled case series vs. self‐controlled risk interval

Self‐controlled case series (SCCS) Self‐controlled risk interval (SCRI)
Typical uses Safety of drugs or vaccines on acute‐onset outcomes Mainly used to study safety of vaccines on acute‐onset outcomes
Who’s included Cases. Patients with the outcome during the study period. Never‐treated patients can be included to contribute to the estimation of time‐varying confounder effects Exposed cases. Patients with the outcome and the exposure during the study period.
Study period Typically calendar year(s) Time immediately surrounding an exposure event.
Design Incidence during risk interval compared to that during baseline time. All time that isn’t part of a risk interval (or a pre‐risk or washout interval, if used) is included as baseline time. Incidence during risk interval compared to that during control interval. Control interval is typically short.
Advantage Greater power than SCRI. All time outside risk periods (and washout + pre‐risk periods) is used as baseline time Less susceptible to time‐varying confounding than SCCS
Disadvantage More susceptible to time‐varying confounding than SCRI due to longer study period. Must be handled through adjustment. Less power than SCCS

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.